Ridamec 1 mg/ml oral solution for sheep
Ridamec 1 mg/ml oral solution for sheep
Authorised
- Moxidectin
Product identification
Medicine name:
Ridamec 1 mg/ml oral solution for sheep
Ridamec Vet 1 mg/ml Oral lösning
Active substance:
- Moxidectin
Target species:
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Moxidectin1.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Sheep
-
Meat and offal14day
-
Milk5day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Package description:
- White HDPE flexi containers containing 1L of product. The containers are closed with an aluminium foil seal and polypropylene tamper-evident caps. The product is marketed in a cardboard outer carton.
- White HDPE flexi containers containing 2.5 L of product. The containers are closed with an aluminium foil seal and polypropylene tamper-evident caps. The product is marketed in a cardboard outer carton.
- White HDPE flexi containers containing 3 L of product. The containers are closed with an aluminium foil seal and polypropylene tamper-evident caps. The product is marketed in a cardboard outer carton.
- White HDPE flexi containers containing 5 L of product. The containers are closed with an aluminium foil seal and polypropylene tamper-evident caps. The product is marketed in a cardboard outer carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 57207
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0403/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Denmark
-
France
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 25/08/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 25/08/2022
How useful was this page?: